Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with the (a) UK Health Security Agency and (b) National Institute for Health and Care Research on studies into diethylstilbestrol-related health risks.

Diethylstilbestrol is a synthetic non-steroidal estrogen medication, which does not fall within the UK Health Security Agency’s remit.

Decisions on topics for new or updated guidance from the National Institute for Health and Care Excellence (NICE) are considered through an established NICE prioritisation process with decisions overseen by a prioritisation board, chaired by NICE’s Chief Medical Officer.